Nicotine / Tobacco

Nicotine is a naturally occurring alkaloid found primarily in tobacco plants (Nicotiana spp.) and now synthesized for use in vaping devices and nicotine replacement therapies. It is one of the most addictive substances known, with both physical and psychological dependence developing rapidly. While nicotine itself is a stimulant with relatively low direct toxicity, the primary route of consumption (smoking tobacco) exposes users to thousands of harmful combustion byproducts, making it one of the leading preventable causes of death globally. Alternative delivery methods (vaping, oral products) reduce but do not eliminate health risks.

How It Works

Nicotine acts as an agonist at nicotinic acetylcholine receptors (nAChRs), particularly at the α4β2 subtype in the brain. This binding leads to dopamine release in the nucleus accumbens (reward pathway), norepinephrine release (arousal), and various peripheral effects through sympathetic nervous system activation. Chronic use leads to receptor desensitization and upregulation, driving tolerance and dependence.

Legal Status

Federally legal in the United States and most countries. Sold as commercial tobacco products (cigarettes, cigars, chewing tobacco, snus, nasal snuff) and as nicotine replacement therapy (FDA-approved). Vaping products containing nicotine are regulated as tobacco products in the US (FDA PMTA required). Minimum purchase age is 21 in the US. Banned or heavily restricted in some countries (e.g., parts of Australia, Singapore). Cannabis co-use with nicotine (spliffs, blunts) may be illegal depending on jurisdiction.

Dosage Guide (Varies significantly by product and delivery method)

Note: One cigarette typically delivers 1-2 mg of nicotine to the user (though contains 6-12 mg total). Vaping devices vary widely; one 'hit' or puff typically delivers 0.5-1.5 mg depending on device (high-nicotine pod systems can deliver 4-6 mg per puff). Tolerance develops rapidly, with heavy smokers consuming 20-40+ cigarettes daily (20-80 mg total nicotine). Lethal dose for pure nicotine in naive adults is estimated at 30-60 mg (0.5-1 mg/kg), but toxicity from nicotine products alone is rare due to lower concentrations and slower absorption.

Organ System Impacts

cardiovascular — Dangerous

Acute: Increased heart rate (10-15 bpm within minutes), elevated blood pressure (+5-10 mmHg systolic), vasoconstriction (reduced peripheral perfusion), increased cardiac workload and myocardial oxygen demand. Chronic: Chronic hypertension, atherosclerosis acceleration (nicotine promotes vascular smooth muscle proliferation, endothelial dysfunction, increased thrombotic tendency), increased arterial stiffness, left ventricular hypertrophy, increased arrhythmia risk. Smoking is responsible for approximately 20% of all cardiovascular deaths in the US.

neurological — Moderate

Acute: Increased alertness, euphoria, mild tremor, dizziness (in naive users). Chronic: Adolescents show impaired prefrontal cortex development (ongoing until ~age 25), deficits in attention and working memory, impulse control problems. Adults show altered dopaminergic signaling and reward processing even during abstinence. Cognitive function may improve with cessation.

ocular — Low

Acute: Irritation and watering (smoke/vapor irritation). Chronic: Smoking increases risk of age-related macular degeneration (AMD), cataracts, and dry eye syndrome. Vaping may cause similar irritation. Secondhand smoke exposure increases pediatric cataract risk.

dermatological — Low

Acute: Nicotine patches may cause contact dermatitis. Smoking stains teeth and skin. Chronic: Smoking accelerates skin aging (collagen breakdown, elastosis), increases wrinkle formation, delays wound healing, increases burn severity (impaired perfusion). Smoking also increases risk of psoriasis exacerbation and delayed healing of ulcers.

respiratory — Dangerous

Acute: Coughing (especially in new inhalers), mild bronchial irritation, increased sputum production (smoking only). Chronic (smoking): COPD, emphysema, chronic bronchitis, lung cancer (4,000+ carcinogens in tobacco smoke; smoking causes 85-90% of lung cancers), asthma exacerbation, reduced lung function, increased respiratory infections. Chronic (vaping): Emerging evidence of airway irritation, potential for chronic inflammation, popcorn lung (diacetyl — now largely removed), lipoid pneumonia (from VG inhalation), reduced antimicrobial defenses.

hepatic — Low

Acute: Minimal acute effects. Chronic: Smoking increases risk of cirrhosis (via increased oxidative stress and inflammatory cytokines; may increase fibrosis progression in hepatitis C). Nicotine alone carries minimal direct hepatotoxicity.

hematological — Moderate

Acute: Increased platelet aggregation and thrombotic tendency (within minutes of smoking). Chronic: Elevated hemoglobin and hematocrit (polycythemia secondary to chronic hypoxia from CO), increased fibrinogen and von Willebrand factor (prothrombotic state), increased blood viscosity. Smoking significantly increases thrombotic risk (myocardial infarction, stroke, pulmonary embolism, deep vein thrombosis).

renal — Low

Acute: Minimal acute effects. Chronic: Smoking increases risk of chronic kidney disease and progression to end-stage renal disease. Nicotine may exacerbate hypertension-related renal damage. Exact mechanisms not fully elucidated but involve endothelial dysfunction and glomerular damage.

gastrointestinal — Low

Acute: Nausea (especially in naive users), increased salivation (particularly with chewing products), mild appetite suppression. Chronic: Smoking increases risk of peptic ulcer disease (increases acid secretion, impairs protective mucus), may exacerbate GERD, increases colorectal cancer risk, increases pancreatic cancer risk (particularly in smokers). Oral products increase risk of oral/esophageal cancers.

musculoskeletal — Low

Acute: Minimal acute effects. Chronic: Smoking impairs bone healing and increases fracture risk (reduced bone mineral density, particularly in postmenopausal women). Smoking also increases risk of osteoporosis, delays fracture healing, and increases post-operative complications. Mechanism involves impaired osteoblast function and increased inflammation.

Effects

Desired Effects

• Increased alertness and focus (central dopaminergic and noradrenergic effects)
• Mild mood elevation and pleasure (dopamine reward pathway activation)
• Reduced appetite (appetite suppression via hypothalamic effects)
• Stress relief and anxiety reduction (paradoxical; often relief from withdrawal rather than true anxiolytic effect)
• Enhanced attention and memory (particularly with repeated use in dependent individuals)
• Relaxation (contradictory to stimulant profile; may reflect relief from withdrawal or mild GABA modulation)

Negative Effects

• Dependence and craving (both physical and psychological; among the strongest of any substance)
• Anxiety and irritability (withdrawal symptoms when access is interrupted)
• Headaches (withdrawal-related or from nicotine overdose)
• Sleep disruption (stimulant effect; insomnia common with evening/night use)
• Jitteriness and tremor (excess sympathetic activation)
• Constipation or diarrhea (nicotinic effects on GI motility)
• Dry mouth
• Nicotine poisoning in acute overdose: severe nausea, vomiting, rapid heart rate, hypertension, confusion, seizures (rare in typical use)
• Cognitive impairment in adolescent users (long-term: affects attention, working memory, impulse control)

Rare but Serious

• Acute nicotine toxicity (seizures, severe hypertension, cardiac arrhythmia) — extremely rare from conventional products; more common with concentrated liquid nicotine exposure or e-liquid ingestion in children
• Myocardial infarction or acute coronary syndrome (precipitated by nicotine's vasoconstrictive and arrhythmogenic effects in susceptible individuals, particularly those with pre-existing cardiac disease)
• Stroke or cerebral hemorrhage (nicotine-induced hypertension and hypercoagulability)
• Sudden cardiac death (rare but documented, particularly in individuals with underlying arrhythmia susceptibility)

Drug Interactions

Detection Times

Cotinine (nicotine metabolite) is the primary marker used for tobacco/nicotine testing.

Urine (Cotinine)

Cotinine urine test is the standard for nicotine detection. Detection window: up to 5 days.

Blood (Cotinine)

Blood cotinine levels indicate recent nicotine exposure. Detection window: up to 3 days.

Hair

Hair nicotine/cotinine testing for long-term use assessment. Detection window: up to 90 days.

Saliva

Salivary cotinine test for recent use. Detection window: up to 4 days.

Harm Reduction Tips

Dose Management

• Gradual dose reduction: Systematically lower nicotine intake over weeks to months, reducing physical dependence and withdrawal severity. Tapering patches or switching to lower-nicotine products helps prevent sudden withdrawal.
• Switching to lower-nicotine vape liquids: Gradually reduce strength (18mg → 12mg → 6mg → 3mg → 0mg), allowing CNS adaptation.
• Avoid nicotine stacking: Using multiple products simultaneously (vaping + gum, patches + gum at high doses) risks overdose and cardiovascular strain. If combining, use only under medical supervision.
• Understand absorption variability: Oral products depend on saliva pH, form, and placement. Maximize buccal absorption by using proper technique (cheek placement for lozenges, proper chewing for gum).

Route Optimization

• Switch from smoking to vaping: Eliminates combustion byproducts (tar, CO, PAHs), reducing cancer and COPD risk by 90%+. Vaping carries ~5% of smoking's health risk for short-term use, though long-term effects are still being studied.
• Switch from vaping to oral nicotine (pouches, lozenges, gum): Bypasses lungs entirely, eliminating respiratory exposure. Ideal for gradual dose reduction. FDA-approved products (Nicorette, Nicoderm, Nicotrol) are validated for safety and efficacy.
• Use transdermal patches: Provides steady-state dosing without behavioral reinforcement or acute reward spikes. Reduces withdrawal symptoms; ideal for combining with behavioral support.
• Avoid oral/buccal tobacco products (snus, chewing tobacco, snuff): While less carcinogenic than smoking for respiratory and cardiovascular disease, these products carry oral and pancreatic cancer risk. Use pharmaceutical-grade oral NRT instead (approved lozenges/gum).
• Never mix nicotine products with cannabis/tobacco: Eliminates added combustion byproducts and reduces carcinogen exposure.

Cardiovascular Protection

• Avoid stimulant co-use: Do not combine nicotine with cocaine, methamphetamine, excess caffeine, or energy drinks. If stimulant use occurs, monitor for chest pain, palpitations, shortness of breath.
• Monitor blood pressure: Check regularly, especially in users with hypertension or cardiovascular risk factors. Nicotine raises BP by 5-10 mmHg acutely.
• Use lower doses: Minimizing nicotine intake reduces sympathomimetic stress. Oral/transdermal products deliver lower peak blood levels than smoking/vaping.
• Exercise and cardiovascular fitness: Regular aerobic exercise improves vascular function and mitigates some nicotine-related cardiovascular stress.
• Manage other risk factors: Hypertension, diabetes, and lipid disorders should be treated aggressively in nicotine users. Smoking cessation is the single most important intervention for cardiovascular health.

Respiratory Health (for continuing use)

• If vaping: Choose reputable e-liquid brands; avoid diacetyl-containing liquids (now banned in most jurisdictions). Use high-quality devices with proper temperature control to avoid excessive heating/degradation of PG/VG.
• If smoking: Reduce cigarette consumption. Switching to 'light' cigarettes does not meaningfully reduce harm (smokers often compensate by inhaling more deeply/frequently). Number of cigarettes is what matters most.
• Smoking cessation support: Behavioral counseling + pharmacotherapy (NRT, bupropion, varenicline) dramatically improves success rates (30-50% vs. 3-5% for willpower alone).
• Use N-acetylcysteine (NAC) supplementation: May reduce oxidative stress; emerging evidence for adjunct benefit in smokers attempting cessation.
• Lung cancer screening: Smokers with >30 pack-year history should discuss low-dose CT screening with physicians (USPSTF recommendation).

Dependence and Withdrawal Management

• Plan cessation with medical support: Working with a healthcare provider or quit-smoking program (e.g., quitsmokingplan.com, tobacco quitlines at 1-800-QUIT-NOW in the US) increases success rates.
• Use evidence-based pharmacotherapy: Varenicline (Chantix) is most effective single agent (NRT has lower efficacy alone but can be combined); bupropion (Wellbutrin) is alternative. NRT patches, gum, lozenges, nasal spray can be combined for breakthrough cravings.
• Manage withdrawal symptoms systematically: Irritability/anxiety (reduce caffeine, exercise, meditation, consider short-term anxiolytic under medical supervision), sleep disruption (avoid evening nicotine, sleep hygiene measures), appetite changes (healthy snacks, sugar-free gum), concentration difficulty (temporary; time and behavioral supports help).
• Address psychological dependence: Behavioral counseling, cognitive-behavioral therapy (CBT), mindfulness/meditation, and identifying and avoiding triggers are critical alongside pharmacotherapy.
• Support network: Engaging family, friends, or quit-smoking groups significantly improves long-term abstinence rates.

Adolescent/Pregnancy Precautions

• CRITICAL: Adolescents should not use nicotine. Adolescent nicotine exposure impairs prefrontal cortex development (ongoing until age 25), causing lasting deficits in attention, impulse control, and decision-making. Nicotine is also uniquely addictive in developing brains due to greater synaptic plasticity.
• If pregnant or planning pregnancy: Nicotine itself is not a proven teratogen at typical doses, but smoking carries severe risks to fetus (prematurity, low birth weight, sudden infant death, congenital anomalies from other smoke components). If cessation is difficult, NRT (patches, gum, lozenges) is safer than smoking and can be used under OB/GYN guidance.
• Lactation: Nicotine passes into breastmilk. If breastfeeding, use lowest effective dose of NRT or consider cessation.

Secondhand Smoke Avoidance

• Do not smoke around others, especially children and pregnant individuals. Secondhand smoke carries 3,000+ chemicals and 70+ known carcinogens.
• If living with smoker: Request they smoke outside or in separate, well-ventilated space. Thirdhand smoke (residue on surfaces) is toxic to children.
• Advocate for smoke-free environments in workplaces, public spaces.

Testing & Product Quality

• Commercial tobacco products do not require testing (no adulteration market). However, illicit vape products may contain vitamin E acetate (associated with EVALI — e-cigarette or vaping product use-associated lung injury) and other contaminants.
• Purchase only from licensed retailers. Avoid counterfeit e-liquid or devices (particularly from unlicensed online vendors or street sources).
• For nicotine replacement: Use FDA-approved products only (Nicorette gum, Nicoderm patch, Nicotrol inhaler/nasal spray, generic equivalents). These are rigorously tested.

Medical Monitoring

• Baseline and periodic assessment: Users with cardiovascular risk factors should have baseline EKG and blood pressure monitoring.
• Drug interactions: Inform all healthcare providers of nicotine use. Smoking status significantly affects dosing of many medications (warfarin, methadone, antipsychotics, antiarrhythmics, theophylline, tramadol).
• Cessation success: Relapse rates are extremely high (70-90% within 1 year without intervention). Multiple quit attempts are normal; persistence is key.

Withdrawal Symptoms

Severity: Moderate

Onset: 2-12 hours after last use. Peak: days 2-3. Most physical symptoms: 2-4 weeks. Cravings: can persist for months. Psychological habit triggers: long-term.

Physical

• Increased appetite and weight gain
• Headaches
• Constipation
• Tingling in hands and feet
• Coughing and sore throat (lungs clearing)
• Insomnia or disturbed sleep

Psychological

• Intense cravings
• Irritability and anger
• Anxiety
• Difficulty concentrating
• Depressed mood
• Restlessness and impatience

Emergency Information

Call 911 If:

• Chest pain, pressure, or discomfort (possible acute coronary syndrome)
• Shortness of breath or respiratory distress
• Loss of consciousness or severe confusion
• Seizure activity
• Severe hypertension (BP >180/120 mmHg) with symptoms (headache, vision changes, chest pain)
• Rapid, irregular, or severely elevated heart rate (>120 bpm, palpitations, chest palpitations) with symptoms
• Suspected nicotine ingestion in a child (highly toxic in small amounts)
• Any neurological symptoms (severe tremor, altered mental status, paralysis)

Warning Signs

• Acute nicotine toxicity (rare from commercial products, possible from pure nicotine liquid or e-liquid ingestion, particularly in children):
• - Severe nausea and vomiting
• - Tremor, agitation, confusion
• - Rapid or irregular heartbeat (tachycardia, arrhythmia)
• - Severe hypertension (BP >180/120 mmHg)
• - Seizures
• - Loss of consciousness
• - Respiratory depression
• Nicotine-precipitated acute coronary syndrome or arrhythmia (in susceptible individuals):
• - Chest pain or pressure
• - Shortness of breath
• - Palpitations or irregular heartbeat
• - Severe anxiety or sense of impending doom
• - Diaphoresis (sweating), pallor
• Nicotine-induced acute hypertensive episode:
• - Severe headache
• - Vision changes
• - Chest discomfort
• - Epistaxis (nosebleed)
• Nicotine ingestion (particularly in children):
• - Same as acute toxicity above; onset typically 15-45 minutes after ingestion

What To Do

1. ACUTE TOXICITY (non-life-threatening): Remove source of nicotine exposure. Activated charcoal if ingestion occurred within 1 hour (not vomiting unless advised by poison control). Place supine, elevate legs. Provide supportive care.
2. ACUTE CORONARY SYMPTOMS or SEVERE HYPERTENSION: Call 911 immediately. Do not delay. Sit patient upright, provide reassurance, monitor breathing. Aspirin (if not contraindicated) may be given while awaiting ambulance.
3. SEIZURE: Call 911. Protect airway, turn head to side, prevent falls/trauma. Do not restrain. Loosen tight clothing. Monitor breathing.
4. RESPIRATORY DEPRESSION or LOSS OF CONSCIOUSNESS: Call 911 immediately. Ensure airway patency. Be prepared to perform rescue breathing if trained.
5. GENERAL: Avoid further nicotine exposure. Monitor vital signs (HR, BP, O2 saturation if available). Keep patient calm and reassured. Do not leave unattended.